Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | AXL receptor tyrosine kinase | Starlite/ChEMBL | References |
Homo sapiens | MER proto-oncogene, tyrosine kinase | Starlite/ChEMBL | References |
Homo sapiens | TYRO3 protein tyrosine kinase | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Schistosoma japonicum | IPR008957,Fibronectin, type III-like fold,domain-containing | Get druggable targets OG5_132328 | All targets in OG5_132328 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0017 | 0.194 | 0.3192 |
Echinococcus granulosus | nephrin | 0.0017 | 0.194 | 0.194 |
Echinococcus granulosus | neuroglian | 0.0021 | 0.3922 | 0.3922 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.0017 | 0.194 | 0.3192 |
Loa Loa (eye worm) | hypothetical protein | 0.0021 | 0.3922 | 0.6452 |
Echinococcus multilocularis | insulin growth factor 1 receptor beta | 0.0018 | 0.2163 | 0.2163 |
Loa Loa (eye worm) | hypothetical protein | 0.0025 | 0.6078 | 1 |
Loa Loa (eye worm) | CAMK/MLCK protein kinase | 0.0021 | 0.3922 | 0.6452 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.0017 | 0.194 | 0.3192 |
Trypanosoma brucei | Fibronectin type III domain containing protein, putative | 0.0014 | 0 | 0.5 |
Loa Loa (eye worm) | immunoglobulin I-set domain-containing protein | 0.0017 | 0.194 | 0.3192 |
Echinococcus multilocularis | contactin neuroglian septate junction protein | 0.0021 | 0.3922 | 0.3922 |
Onchocerca volvulus | 0.0017 | 0.194 | 1 | |
Schistosoma mansoni | hemicentin | 0.0017 | 0.194 | 0.2407 |
Schistosoma mansoni | cell adhesion molecule | 0.0017 | 0.194 | 0.2407 |
Schistosoma mansoni | hypothetical protein | 0.0017 | 0.194 | 0.2407 |
Loa Loa (eye worm) | CAMK protein kinase | 0.0017 | 0.194 | 0.3192 |
Echinococcus multilocularis | neuroglian | 0.0015 | 0.0662 | 0.0662 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.0021 | 0.3922 | 0.6452 |
Echinococcus granulosus | roundabout 2 | 0.0021 | 0.3922 | 0.3922 |
Echinococcus multilocularis | transfer RNA-Phe | 0.0017 | 0.194 | 0.194 |
Loa Loa (eye worm) | hypothetical protein | 0.0018 | 0.2643 | 0.4349 |
Brugia malayi | protein unc-22 | 0.0017 | 0.194 | 0.3192 |
Echinococcus multilocularis | neuroglian | 0.0021 | 0.3922 | 0.3922 |
Loa Loa (eye worm) | immunoglobulin I-set domain-containing protein | 0.0017 | 0.194 | 0.3192 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.0017 | 0.1982 | 0.326 |
Echinococcus multilocularis | receptor type tyrosine protein phosphatase | 0.0021 | 0.3922 | 0.3922 |
Echinococcus granulosus | titin | 0.0017 | 0.194 | 0.194 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.0019 | 0.2866 | 0.4715 |
Schistosoma mansoni | cell adhesion molecule | 0.0028 | 0.806 | 1 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.0021 | 0.3922 | 0.6452 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.0017 | 0.194 | 0.3192 |
Echinococcus multilocularis | roundabout 2 | 0.0021 | 0.3922 | 0.3922 |
Schistosoma mansoni | myosin-binding protein-related | 0.0017 | 0.194 | 0.2407 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.0017 | 0.194 | 0.3192 |
Loa Loa (eye worm) | hypothetical protein | 0.0015 | 0.0703 | 0.1156 |
Echinococcus granulosus | roundabout 2 | 0.0021 | 0.3922 | 0.3922 |
Echinococcus granulosus | neurotracting:lsamp:neurotrimin:obcam | 0.0015 | 0.0703 | 0.0703 |
Loa Loa (eye worm) | hypothetical protein | 0.0025 | 0.6078 | 1 |
Echinococcus granulosus | receptor type tyrosine protein phosphatase | 0.0021 | 0.3922 | 0.3922 |
Loa Loa (eye worm) | immunoglobulin I-set domain-containing protein | 0.0017 | 0.1982 | 0.326 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.0025 | 0.6078 | 1 |
Schistosoma mansoni | cell adhesion molecule | 0.0017 | 0.194 | 0.2407 |
Echinococcus granulosus | twitchin | 0.0015 | 0.0662 | 0.0662 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.0021 | 0.3922 | 0.6452 |
Echinococcus granulosus | insulin growth factor 1 receptor beta | 0.0018 | 0.2163 | 0.2163 |
Schistosoma mansoni | neuroglian | 0.0021 | 0.3922 | 0.4866 |
Schistosoma mansoni | cell adhesion molecule | 0.0021 | 0.3922 | 0.4866 |
Schistosoma mansoni | titin | 0.0017 | 0.194 | 0.2407 |
Schistosoma mansoni | titin | 0.0017 | 0.194 | 0.2407 |
Onchocerca volvulus | 0.0017 | 0.194 | 1 | |
Loa Loa (eye worm) | immunoglobulin I-set domain-containing protein | 0.0021 | 0.3922 | 0.6452 |
Schistosoma mansoni | cell adhesion molecule | 0.0021 | 0.3922 | 0.4866 |
Echinococcus multilocularis | receptor type tyrosine protein phosphatase | 0.0021 | 0.3922 | 0.3922 |
Onchocerca volvulus | 0.0017 | 0.194 | 1 | |
Echinococcus granulosus | Down syndrome cell adhesion molecule | 0.0017 | 0.1982 | 0.1982 |
Echinococcus multilocularis | roundabout 2 | 0.0021 | 0.3922 | 0.3922 |
Loa Loa (eye worm) | hypothetical protein | 0.0025 | 0.6078 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0014 | 0 | 0.5 |
Trypanosoma cruzi | Fibronectin type III domain containing protein, putative | 0.0014 | 0 | 0.5 |
Loa Loa (eye worm) | projectin | 0.0017 | 0.194 | 0.3192 |
Loa Loa (eye worm) | TK/KIN16 protein kinase | 0.0019 | 0.2866 | 0.4715 |
Loa Loa (eye worm) | hypothetical protein | 0.0017 | 0.194 | 0.3192 |
Schistosoma mansoni | receptor tyrosine phosphatase type r2a | 0.0021 | 0.3922 | 0.4866 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0017 | 0.194 | 0.2407 |
Trypanosoma cruzi | Fibronectin type III domain containing protein, putative | 0.0014 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0018 | 0.2643 | 0.4349 |
Echinococcus granulosus | contactin | 0.0021 | 0.3922 | 0.3922 |
Schistosoma mansoni | nephrin | 0.0021 | 0.3922 | 0.4866 |
Echinococcus multilocularis | titin | 0.0017 | 0.194 | 0.194 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.0017 | 0.194 | 0.3192 |
Echinococcus granulosus | receptor type tyrosine protein phosphatase | 0.0017 | 0.194 | 0.194 |
Echinococcus multilocularis | roundabout 2 | 0.0032 | 1 | 1 |
Loa Loa (eye worm) | CAMK/MLCK protein kinase | 0.0017 | 0.194 | 0.3192 |
Echinococcus granulosus | neuroglian | 0.0015 | 0.0662 | 0.0662 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.0017 | 0.194 | 0.3192 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.0017 | 0.194 | 0.3192 |
Schistosoma mansoni | ephrin receptor | 0.0018 | 0.2163 | 0.2684 |
Brugia malayi | hypothetical protein | 0.0025 | 0.6078 | 1 |
Echinococcus granulosus | titin | 0.0017 | 0.194 | 0.194 |
Schistosoma mansoni | nephrin | 0.0028 | 0.8018 | 0.9949 |
Leishmania major | hypothetical protein, conserved | 0.0014 | 0 | 0.5 |
Brugia malayi | Fibronectin type III domain containing protein | 0.0025 | 0.6078 | 1 |
Echinococcus multilocularis | receptor type tyrosine protein phosphatase F | 0.0021 | 0.3922 | 0.3922 |
Loa Loa (eye worm) | immunoglobulin I-set domain-containing protein | 0.0017 | 0.194 | 0.3192 |
Echinococcus multilocularis | Down syndrome cell adhesion molecule | 0.0017 | 0.1982 | 0.1982 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 14 nM | Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay | ChEMBL. | 24195762 |
IC50 (binding) | = 80 nM | Inhibition of Tyro-3 kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay | ChEMBL. | 24195762 |
IC50 (binding) | = 430 nM | Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay | ChEMBL. | 24195762 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.